{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:37:43Z","timestamp":1790617063048,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.humpath.2003.10.006","type":"journal-article","created":{"date-parts":[[2004,2,26]],"date-time":"2004-02-26T13:25:52Z","timestamp":1077801952000},"page":"184-189","source":"Crossref","is-referenced-by-count":24,"title":["Muscle invasive schistosomal squamous cell carcinoma of the urinary bladder: frequency and prognostic significance of p53, BCL-2, HER2\/neu, and proliferation (MIB-1)"],"prefix":"10.1016","volume":"35","author":[{"given":"Khaled M","family":"Badr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.L","family":"Nolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia B","family":"Derose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2003.10.006_BIB1","series-title":"Tumors of the Kidney, Bladder, and Related Urinary Structures","author":"Murphy","year":"1994"},{"key":"10.1016\/j.humpath.2003.10.006_BIB2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0022-5347(01)64487-2","article-title":"Radical cystectomy for carcinoma of the bladder","volume":"158","author":"Ghoneim","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2003.10.006_BIB3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1464-410X.1992.tb15560.x","article-title":"Squamous cell carcinoma of the urinary bladder","volume":"69","author":"Sharfi","year":"1992","journal-title":"Br J Urol"},{"key":"10.1016\/j.humpath.2003.10.006_BIB4","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1464-410X.1982.tb13580.x","article-title":"Squamous cell carcinoma of bladder","volume":"54","author":"Rundle","year":"1982","journal-title":"Br J Urol"},{"key":"10.1016\/j.humpath.2003.10.006_BIB5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00345-002-0279-y","article-title":"Prognostic markers in muscle invasive bladder cancer","volume":"20","author":"Tiguert","year":"2002","journal-title":"World J Urol"},{"key":"10.1016\/j.humpath.2003.10.006_BIB6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF00190555","article-title":"p53 and c-erbB-2 expression in schistosomal urinary bladder carcinomas and schistosomal cystitis with pre-malignant lesions","volume":"424","author":"Kamel","year":"1994","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2003.10.006_BIB7","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/carcin\/16.5.1181","article-title":"Mutations in the p53 gene in schistosomal bladder cancer","volume":"16","author":"Warren","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.humpath.2003.10.006_BIB8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1464-410X.1997.30717.x","article-title":"Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous carcinoma of urinary bladder","volume":"79","author":"Chaudhary","year":"1997","journal-title":"Br J Urol"},{"key":"10.1016\/j.humpath.2003.10.006_BIB9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ijc.2910620302","article-title":"Molecular events underlying schistosomiasis-related bladder cancer","volume":"62","author":"Ramchurren","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2003.10.006_BIB10","first-page":"9","article-title":"p53 mutation and bcl-2 expression in transitional cell carcinoma of the urinary bladder","volume":"64","author":"Wu","year":"2001","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"key":"10.1016\/j.humpath.2003.10.006_BIB11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1096-9896(199601)178:1<65::AID-PATH451>3.0.CO;2-W","article-title":"p53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder","volume":"178","author":"Tenti","year":"1996","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2003.10.006_BIB12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000475038","article-title":"p53 and Rb immunostaining in locally advanced bladder cancer","volume":"28","author":"Jahnson","year":"1995","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2003.10.006_BIB13","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0344-0338(97)80055-6","article-title":"The role of p53, MDM2 and c-erbB-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer","volume":"193","author":"Korkolopoulou","year":"1997","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.humpath.2003.10.006_BIB14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3835(97)00532-6","article-title":"Investigation of p53, c-cerbB-2, PCNA immunoreactivity, DNA content, AgNOR and apoptosis in bladder carcinoma as prognostic parameters","volume":"126","author":"Koyuncuoglu","year":"1998","journal-title":"Cancer Lett"},{"key":"10.1016\/j.humpath.2003.10.006_BIB15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000163788","article-title":"Interrelationship between expression of p53, proliferating cell nuclear antigen and c-erbB-2 in bladder cancer","volume":"61","author":"Lipponen","year":"1993","journal-title":"Pathobiology"},{"key":"10.1016\/j.humpath.2003.10.006_BIB16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF01607144","article-title":"p53 and erbB-2 protein overexpression are associated with early invasion and metastasis in bladder cancer","volume":"423","author":"Moch","year":"1993","journal-title":"Virchows Arch A"},{"key":"10.1016\/j.humpath.2003.10.006_BIB17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0046-8177(98)90225-8","article-title":"The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates","volume":"29","author":"Nakopoulou","year":"1998","journal-title":"HUM PATHOL"},{"key":"10.1016\/j.humpath.2003.10.006_BIB18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s002400050051","article-title":"Reciprocal expression of bcl-2 and p53 oncoproteins in urothelial dysplasia and carcinoma of the urinary bladder","volume":"26","author":"Li","year":"1998","journal-title":"Urol Res"},{"key":"10.1016\/j.humpath.2003.10.006_BIB19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00280-002-0467-x","article-title":"Bcl-2-negative MCF7 cells overexpress p53","volume":"50","author":"Poliseno","year":"2002","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.humpath.2003.10.006_BIB20","first-page":"205","article-title":"Role of three cancer \u201cmaster genes\u201d p53, bcl-2, and c-myc on the apoptotic process","volume":"82","author":"Chiarugi","year":"1996","journal-title":"Tumori"},{"key":"10.1016\/j.humpath.2003.10.006_BIB21","first-page":"758","article-title":"Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erb-B-2 gene product in transitional cell carcinoma of the urinary bladder","volume":"8","author":"Gorgoulis","year":"1995","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2003.10.006_BIB22","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0959-8049(05)80360-0","article-title":"Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer","volume":"29A","author":"Lipponen","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2003.10.006_BIB23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2559.1994.tb01375.x","article-title":"Usefulness of MIB1 monoclonal antibody in assessing the proliferative index in human bladder carcinoma","volume":"25","author":"Mazerolles","year":"1994","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2003.10.006_BIB24","first-page":"213","article-title":"The prognostic significance of proliferation in prostate cancer","volume":"4","author":"Goel","year":"1996","journal-title":"J Urol Pathol"},{"key":"10.1016\/j.humpath.2003.10.006_BIB25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/(SICI)1097-0142(19960815)78:4<827::AID-CNCR20>3.0.CO;2-W","article-title":"The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract","volume":"78","author":"Chowdhury","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2003.10.006_BIB26","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000019580","article-title":"Comparative analysis of MiB1 and p53 expression in human bladder tumors and their correlation with cancer progression","volume":"33","author":"Pfister","year":"1998","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2003.10.006_BIB27","series-title":"American Joint Committee on Cancer Staging Manual","year":"1997"},{"key":"10.1016\/j.humpath.2003.10.006_BIB28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/(SICI)1097-0320(20000215)42:1<61::AID-CYTO9>3.0.CO;2-5","article-title":"Bcl-2: bax and bcl-2:bcl-x ratios by image cytometric quantitation of immunohistochemical expression in ovarian carcinoma: Correlation with prognosis","volume":"42","author":"Lohmann","year":"2000","journal-title":"Cytometry (Comm Clin Cytometry)"},{"key":"10.1016\/j.humpath.2003.10.006_BIB29","first-page":"91","article-title":"Image analysis for quantitation of estrogen receptor in formalin-fixed, paraffin embedded sections of breast carcinoma","volume":"4","author":"Baddoura","year":"1991","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2003.10.006_BIB30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/107327480000700401","article-title":"Molecular mechanisms and pathways in bladder cancer development and progression","volume":"7","author":"Jung","year":"2002","journal-title":"Cancer Control"},{"key":"10.1016\/j.humpath.2003.10.006_BIB31","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0090-4295(98)00626-8","article-title":"Numerical chromosomal aberrations in muscle invasive squamous cell and transitional cell cancer of the urinary bladder","volume":"53","author":"Pycha","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.humpath.2003.10.006_BIB32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/ejso.1998.0601","article-title":"Can p53 nuclear over-expression, Bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours?","volume":"25","author":"Plastiras","year":"1999","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.humpath.2003.10.006_BIB33","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0022-5347(01)63614-0","article-title":"Expression of bcl-2 and bcl-x in bladder cancer","volume":"159","author":"Kirsh","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2003.10.006_BIB34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2559.1996.276322.x","article-title":"Expression of the apoptosis suppressing bcl-2 protein in transitional cell bladder tumors","volume":"28","author":"Lipponen","year":"1996","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2003.10.006_BIB35","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/0046-8177(94)90096-5","article-title":"p53 but not erbB-2 expression is associated with rapid tumor proliferation in urinary bladder cancer","volume":"25","author":"Moch","year":"1994","journal-title":"HUM PATHOL"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817703006038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817703006038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T04:09:17Z","timestamp":1585627757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817703006038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0046817703006038"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2003.10.006","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}